Flumazenil Injection, Solution
Product Images NDC 0404-9793

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 0404-9793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram of flumazenil, the active ingredient in FLUMAZENIL injection solution .1 mg/mL by Henry Schein, Inc. The structure shows the molecular arrangement including a fluorinated benzodiazepine core with attached functional groups.*

FDA Label Image

Image1.jpg (Image1)

A chart showing the magnitude and duration of reversal of sedation as a function of flumazenil dose (0.2 mg, 0.6 mg, 1 mg) by alertness levels over 100 minutes after flumazenil injection. The y-axis represents alertness levels from sedated to completely alert, and the x-axis shows time in minutes. The chart indicates varying blood levels of flumazenil and sedation statuses including baseline sedation, awake, and completely alert.*

FDA Label Image

Image2.jpg (Image2)

A pharmacokinetic data table presenting metrics for flumazenil, including Cmax (ng/mL), AUC (ng·hr/mL), volume of distribution at steady state (Vss, L/kg), clearance (Cl, L/hr/kg), and half-life (min). Each metric includes a mean value and variability range in parentheses.*

FDA Label Image

Image3.jpg (Image3)

A text panel providing safety information about flumazenil use, highlighting its association with seizures, especially in patients on long-term benzodiazepines or with cyclic antidepressant overdose. It advises practitioners to individualize dosage and be prepared to manage seizures.*

FDA Label Image

Label1.jpg (Label1jpg)

Flumazenil injection, USP, 0.1 mg/mL in a 5 mL multiple dose vial. The label specifies intravenous use only and sterile product conditions. It includes storage instructions, manufacturer details (Henry Schein, Inc.), and indicates it is a prescription-only drug. The NDC code is 0404-9793-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.